133 related articles for article (PubMed ID: 16026938)
1. Therapeutic thresholds in methadone maintenance treatment: a receiver operating characteristic analysis.
Hallinan R; Ray J; Byrne A; Agho K; Attia J
Drug Alcohol Depend; 2006 Feb; 81(2):129-36. PubMed ID: 16026938
[TBL] [Abstract][Full Text] [Related]
2. Major depressive disorder and patient satisfaction in relation to methadone pharmacokinetics and pharmacodynamics in stabilized methadone maintenance patients.
Elkader AK; Brands B; Dunn E; Selby P; Sproule BA
J Clin Psychopharmacol; 2009 Feb; 29(1):77-81. PubMed ID: 19142113
[TBL] [Abstract][Full Text] [Related]
3. Utilization of plasma and urine methadone concentration measurements to limit narcotics use in methadone maintenance patients: II. Generation of plasma concentration response curves.
Kell MJ
J Addict Dis; 1995; 14(1):85-108. PubMed ID: 7632750
[TBL] [Abstract][Full Text] [Related]
4. Problem drinking in relation to treatment outcome among opiate addicts in methadone maintenance treatment.
Stenbacka M; Beck O; Leifman A; Romelsjö A; Helander A
Drug Alcohol Rev; 2007 Jan; 26(1):55-63. PubMed ID: 17364837
[TBL] [Abstract][Full Text] [Related]
5. Steady-state pharmacokinetics and pharmacodynamics in methadone maintenance patients: comparison of those who do and do not experience withdrawal and concentration-effect relationships.
Dyer KR; Foster DJ; White JM; Somogyi AA; Menelaou A; Bochner F
Clin Pharmacol Ther; 1999 Jun; 65(6):685-94. PubMed ID: 10391674
[TBL] [Abstract][Full Text] [Related]
6. When "enough" is not enough: new perspectives on optimal methadone maintenance dose.
Leavitt SB; Shinderman M; Maxwell S; Eap CB; Paris P
Mt Sinai J Med; 2000; 67(5-6):404-11. PubMed ID: 11064491
[TBL] [Abstract][Full Text] [Related]
7. Plasma concentrations of the enantiomers of methadone and therapeutic response in methadone maintenance treatment.
Eap CB; Bourquin M; Martin J; Spagnoli J; Livoti S; Powell K; Baumann P; Déglon J
Drug Alcohol Depend; 2000 Dec; 61(1):47-54. PubMed ID: 11064183
[TBL] [Abstract][Full Text] [Related]
8. Factors predicting retention in treatment: 10-year experience of a methadone maintenance treatment (MMT) clinic in Israel.
Peles E; Schreiber S; Adelson M
Drug Alcohol Depend; 2006 May; 82(3):211-7. PubMed ID: 16219428
[TBL] [Abstract][Full Text] [Related]
9. Factors affecting the outcome of methadone maintenance treatment in opiate dependence.
Kamal F; Flavin S; Campbell F; Behan C; Fagan J; Smyth R
Ir Med J; 2007 Mar; 100(3):393-7. PubMed ID: 17491538
[TBL] [Abstract][Full Text] [Related]
10. Increased (R)-methadone plasma concentrations by quetiapine in cytochrome P450s and ABCB1 genotyped patients.
Uehlinger C; Crettol S; Chassot P; Brocard M; Koeb L; Brawand-Amey M; Eap CB
J Clin Psychopharmacol; 2007 Jun; 27(3):273-8. PubMed ID: 17502774
[TBL] [Abstract][Full Text] [Related]
11. ABCB1 and cytochrome P450 genotypes and phenotypes: influence on methadone plasma levels and response to treatment.
Crettol S; Déglon JJ; Besson J; Croquette-Krokar M; Hämmig R; Gothuey I; Monnat M; Eap CB
Clin Pharmacol Ther; 2006 Dec; 80(6):668-81. PubMed ID: 17178267
[TBL] [Abstract][Full Text] [Related]
12. Comparing drug-related hospital morbidity following heroin dependence treatment with methadone maintenance or naltrexone implantation.
Ngo HT; Tait RJ; Hulse GK
Arch Gen Psychiatry; 2008 Apr; 65(4):457-65. PubMed ID: 18391134
[TBL] [Abstract][Full Text] [Related]
13. [Methadone blood assay by the FPIA technique: application to the monitoring of patients in maintenance treatment to opiates].
Boglione-Kerrien C; Furet Y; Bachellier J; Paintaud G; Autret-Leca E
Ann Biol Clin (Paris); 2007; 65(1):51-7. PubMed ID: 17264039
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of levo-alpha-acetylmethdol (LAAM) as an alternative treatment for methadone maintenance patients who regularly experience withdrawal: a pharmacokinetic and pharmacodynamic analysis.
Newcombe DA; Bochner F; White JM; Somogyi AA
Drug Alcohol Depend; 2004 Oct; 76(1):63-72. PubMed ID: 15380290
[TBL] [Abstract][Full Text] [Related]
15. Pathological gambling in methadone maintenance clinics where gambling is legal versus illegal.
Peles E; Schreiber S; Linzy S; Adelson M
Am J Orthopsychiatry; 2010 Jul; 80(3):311-6. PubMed ID: 20636936
[TBL] [Abstract][Full Text] [Related]
16. Opiate-dependent patients receiving methadone. How physicians should manage therapy.
Kahan M; Sutton N
Can Fam Physician; 1996 Sep; 42():1769-78. PubMed ID: 8828879
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of long QTc interval in methadone maintenance patients.
Fonseca F; Marti-Almor J; Pastor A; Cladellas M; Farré M; de la Torre R; Torrens M
Drug Alcohol Depend; 2009 Jan; 99(1-3):327-32. PubMed ID: 18774239
[TBL] [Abstract][Full Text] [Related]
18. Opioid plasma concentrations in methadone-and buprenorphine-maintained patients.
Jagsch R; Gombas W; Schindler SD; Eder H; Moody DE; Fischer G
Addict Biol; 2005 Dec; 10(4):365-71. PubMed ID: 16318959
[TBL] [Abstract][Full Text] [Related]
19. Depression in methadone maintenance treatment patients: rate and risk factors.
Peles E; Schreiber S; Naumovsky Y; Adelson M
J Affect Disord; 2007 Apr; 99(1-3):213-20. PubMed ID: 17055063
[TBL] [Abstract][Full Text] [Related]
20. Effect of saquinavir/ritonavir (1000/100 mg bid) on the pharmacokinetics of methadone in opiate-dependent HIV-negative patients on stable methadone maintenance therapy.
Jamois C; Smith P; Morrison R; Riek M; Patel A; Schmitt C; Morcos PN; Zhang X
Addict Biol; 2009 Jul; 14(3):321-7. PubMed ID: 19523046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
